Isaac Cheng Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

AMLX Quotes by TradingView

Isaac Cheng is Director of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 6,578 shares of AMLX, which is worth approximately $32,626. The most recent transaction as insider was on Jan 06, 2022, when has been sold 6,578 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $124,982. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.58K
0% 3M change
0% 12M change
Total Value Held $32,626

Isaac Cheng Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2022
BUY
Open market or private purchase
$124,982 $19.0 p/Share
6,578 Added 50.0%
6,578 Common Stock

Also insider at

AVIR
Atea Pharmaceuticals, Inc. Healthcare
Director
IC

Isaac Cheng

Director
Boston, MA

Track Institutional and Insider Activities on AMLX

Follow Amylyx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMLX